Plat Street ran "The Pharmacy Box Problem" in Issue 2 on a specific premise: Walgreens closing 1,200 stores, CVS having closed 900 since 2022, and managed corridors absorbing 10,000 to 15,000 square foot anchor vacancies with particular reuse challenges. Issue 2's Frontage companion told merchants what to do when the anchor pharmacy on their corridor closed. Issue 2's Metes & Bounds companion covered the income-approach consequences.

The premise has changed materially, and merchants planning around the old numbers should update.

Under Sycamore Partners' ownership, Walgreens now expects to close fewer than 100 stores in 2026, a shift the company attributes to a tighter store-optimization strategy targeting underperforming individual locations rather than a broad network reduction. The confirmed 2026 closure list spans at least a dozen states and includes urban corridor locations: 1301 Market Street in San Francisco, 2202 Chambers Road in St. Louis, sites in Fort Myers and along Milwaukee's North Avenue. CVS has closed more than 1,100 locations nationally since 2022 and has closed multiple Baltimore locations this year in a city where neighborhood pharmacy access was already strained. Rite Aid completed a full shutdown of its remaining 89 stores after two bankruptcies in two years, with no acquirer emerging.

What changes for a merchant on a corridor with a pharmacy.

The odds that your specific pharmacy closes in the next eighteen months went down, and the basis on which it would close changed. A broad network reduction closes stores by geography and lease expiration. A store-optimization strategy closes stores by individual performance. That means the diagnostic a merchant should run is different: instead of asking whether your chain is in a closure cycle, ask whether your specific location looks like an underperformer: daypart traffic, staffing levels, hours reductions, shrinking front-of-store assortment, pharmacy counter wait times. Hours reductions and assortment contraction are the observable leading indicators, and they precede closure announcements by quarters.

What does not change.

Three things. First, if your pharmacy is one of the fewer-than-100, the corridor consequences Issue 2 described are identical: the anchor vacancy, the foot traffic loss, the reuse difficulty of a purpose-built box. A smaller national number is no comfort to the corridor that draws one.

Second, the CVS and Rite Aid contractions are already in the ground. Rite Aid's 89 remaining stores are gone entirely, and in markets where Rite Aid was the corridor anchor there is no strategy change coming to reverse it.

Third, and most important for anyone doing corridor-health analysis: the backfill picture is better than the closure picture suggested, and it is better for a reason merchants should understand. National shopping center vacancy has run near cyclical lows, supported by historically low new construction deliveries. When almost no new retail space is being built, closures get absorbed by the existing tenant demand rather than compounding into structural vacancy. That is the mechanism that made 2025's closure wave a reshuffle rather than a collapse, and it is also the mechanism that will fail first if construction picks up or if demand softens.

The practical takeaway. Merchants who spent 2026 planning for an anchor departure that has become less likely should redirect that planning energy toward the thing the same data reveals: in a low-construction, low-vacancy environment, the leverage in a lease negotiation sits differently than it did in 2021. Space is scarcer than the closure headlines imply. A merchant renewing in a corridor with genuine demand has less room than the national narrative suggests, and should price a renewal against local availability rather than against the closure-tracker mood.

Editorial note. This piece corrects the forward-looking premise of Issue 2's pharmacy coverage. Plat Street's reporting at the time was accurate to the announced closure plan; the plan changed under new ownership. Say so plainly in the copy. The credibility of a franchise that runs deadline countdowns and multi-issue threads depends on correcting the ones that move.

Watch line: Whether Walgreens publishes a full 2026 closure list, and whether the fewer-than-100 figure holds through Q4. Also: national shopping center vacancy and construction delivery figures for 2026, which determine whether the backfill mechanism is still operating.

Duplicate check: Issue 2 BO ("The Pharmacy Box Problem"), Issue 2 FR ("When the Pharmacy Leaves"), Issue 2 MB ("The Pharmacy Box and Your Income Approach"), Issue 1 platcard. This is a correction and an update; it must name the earlier pieces.

Source: IBTimes UK, August 2026, compiling from Inc.; Coresight Research closure tracking as reported; Cushman & Wakefield U.S. Shopping Center MarketBeat.

Verification note: Confirm the current Walgreens 2026 guidance directly from company statements before publication, and obtain the Cushman & Wakefield vacancy and construction figures from the primary MarketBeat report rather than secondary summary.